Tuberculosis Diagnostics Market Forecast 2024-2033: Projected CAGR, Key Drivers, And Trends

Overview and Scope
Tuberculosis diagnostics refers to a tool or test with high sensitivity and specificity for TB diagnosis and tracking the effectiveness of treatment. Tuberculosis diagnostics are used to identify acid-fast bacilli (AFB) in clinical specimens and to detect tuberculosis.

Sizing and Forecast
The tuberculosis diagnostics market size has grown strongly in recent years. It will grow from $2.11 billion in 2023 to $2.27 billion in 2024 at a compound annual growth rate (CAGR) of 7.7%.  The  growth in the historic period can be attributed to rise in the incidence of tuberculosis, increased healthcare expenditure, growth in the number of healthcare facilities and the rise in the adoption of nucleic acid testing.

The tuberculosis diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.02 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%.  The growth in the forecast period can be attributed to strong government support, the increasing fda approvals for tuberculosis diagnostics, the increasing research and development (r&d) activities and the emergence of drug-resistant tb. Major trends in the forecast period include focus on next generation sequencing (ngs) platform for tb diagnostics, product innovations, t cell tests for tb infection, artificial intelligence (ai)-based tuberculosis diagnostics, use of portable devices and collaborations between governments and manufacturers.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/tuberculosis-diagnostics-global-market-report

Segmentation & Regional Insights
The tuberculosis diagnostics market covered in this report is segmented –
1) By Test Type: Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types
2) By Disease Stage: Latent Tuberculosis, Active Tuberculosis
3) By End-User: Hospitals And Diagnostic Laboratories, Physician’s Office Laboratories, Reference Laboratories, Academics And Research Facilities

Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2023. The regions covered in the tuberculosis diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8165&type=smp

Major Driver Impacting Market Growth
The rise in the incidence of tuberculosis is driving the demand for the tuberculosis diagnostics market going forward. Tuberculosis is an infectious disease that affects the lungs and can be severe. Tuberculosis is spread through coughing and sneezing, releasing tiny germs into the air. Tuberculosis diagnostics aid in patient detection, with earlier diagnosis and detection of diseases. For instance, in March 2022, in the weekly report of the Centers for Disease Control and Prevention, a US-based national public health agency, tuberculosis infections in the United States increased by 9.4% in 2021, with a total of 7,860 TB cases were reported in 2021, an increase from 7,173 cases in 2020. Therefore, the rise in the incidence of tuberculosis is driving the growth of the tuberculosis diagnostics market.

Key Industry Players
Major companies operating in the tuberculosis diagnostics market report are Beckton, Dickinson and Company, F. Hoffmann-La Roche Ltd, Qiagen N.V, BioMerieux SA, Danaher Corporation, PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Techne India Private Limited, Bio-Rad laboratories India Pvt.Ltd, Zhejiang Di'an Diagnostics Technology Co., Ltd, ADICON Clinical Laboratories, Guangzhou Kingmed Diagnostics Center Co. Ltd., Kindstar Global, OriGene Technologies, Siemens AG, Fresenius, Koninklijke Philips, Novartis, LumiraDx Limited, TestLine Clinical Diagnostics s.r.o., Hologic, Bayer AG, Cantel Medical Corporation, Meridian Bioscience, Johnson & Johnson, Abbott laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, Pfizer, Agilent technologies Inc, AutoGenomics, AdvaCare Pharma, Akonni Biosystems Inc, Par Pharmaceutical, Epistem Limited, Gen-Probe, Sysmex South Africa (Pty) Ltd., Grifols S.A., Bio Certica, Biovac, BixBio

The tuberculosis diagnostics market report table of contents includes:
1. Executive Summary
2. Tuberculosis Diagnostics Market Characteristics
3. Tuberculosis Diagnostics Market Trends And Strategies
4. Tuberculosis Diagnostics Market - Macro Economic Scenario
5. Global Tuberculosis Diagnostics Market Size and Growth
…………
32. Global Tuberculosis Diagnostics Market Competitive Benchmarking
33. Global Tuberculosis Diagnostics Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Tuberculosis Diagnostics Market
35. Tuberculosis Diagnostics Market Future Outlook and Potential Analysis
36. Appendix